FDA requires boxed warnings for short-acting opioids

The Food and Drug Administration will require boxed warnings on the risks of abuse, misuse, addiction, overdose, and death for all immediate-release opioids. The decision is part of the latest wave...
Source: Rheumatology News - Category: Rheumatology Source Type: research